This webinar will discuss the FDA requirements and guidelines for investigating Out-of-trend (OOT) results in the pharmaceutical laboratory. It will also cover FDA-compliant documentation of OOT, failure investigations, root causes, and CAPA.
WHY SHOULD YOU ATTEND?
FDA's guidance on OOS test results requires failure investigations and other steps for Out-of-Specification (OOS) and Out-of-trend (OOT) results. While most companies are familiar with and have procedures for OOS results, this is not the case for OOT situations. The guide states: "Although the subject of this document is OOS results, much of the guidance may be useful for examining results that are out of trend". Managing OOT results also helps to avoid time-consuming OOS results. The industry is unsure how to interpret and implement the FDA guidance.
This session will equip you with the knowledge and comprehensive understanding of FDA requirements for Out-of-Trend Results in pharmaceutical quality control.
AREA COVERED
- FDA regulations and guidelines.
- FDA's final Guidance for Industry: Investigating Out-of-Specification (OOS) Test Results for Pharmaceutical Production.
- Difference between OOS and OOT results.
- Developing SOPs for OOT situations and laboratory failures.
- Investigating OOT results: what and how.
- Retesting of OOT results.
- Using historical data for OOT evaluation.
- Using QC samples and product control charts for evaluation.
- Developing corrective and preventive action plans.
- Finding the root cause for OOT results.
- Strategies to avoid OOS situations BEFORE they occur.
- FDA-compliant documentation of OOS, OOT, failure investigations, root causes, and CAPA.
WHO WILL BENEFIT?
- Lab Supervisors and Managers
- QA managers and personnel
- Pharmaceutical R&D personnel
- Documentation
- Consultants
- Contract laboratories
- CROs
FDA's guidance on OOS test results requires failure investigations and other steps for Out-of-Specification (OOS) and Out-of-trend (OOT) results. While most companies are familiar with and have procedures for OOS results, this is not the case for OOT situations. The guide states: "Although the subject of this document is OOS results, much of the guidance may be useful for examining results that are out of trend". Managing OOT results also helps to avoid time-consuming OOS results. The industry is unsure how to interpret and implement the FDA guidance.
This session will equip you with the knowledge and comprehensive understanding of FDA requirements for Out-of-Trend Results in pharmaceutical quality control.
- FDA regulations and guidelines.
- FDA's final Guidance for Industry: Investigating Out-of-Specification (OOS) Test Results for Pharmaceutical Production.
- Difference between OOS and OOT results.
- Developing SOPs for OOT situations and laboratory failures.
- Investigating OOT results: what and how.
- Retesting of OOT results.
- Using historical data for OOT evaluation.
- Using QC samples and product control charts for evaluation.
- Developing corrective and preventive action plans.
- Finding the root cause for OOT results.
- Strategies to avoid OOS situations BEFORE they occur.
- FDA-compliant documentation of OOS, OOT, failure investigations, root causes, and CAPA.
- Lab Supervisors and Managers
- QA managers and personnel
- Pharmaceutical R&D personnel
- Documentation
- Consultants
- Contract laboratories
- CROs
Speaker Profile

Ms. Thomas has over two decades of cGMP hands-on industry experience in both pharmaceutical and medical device manufacturing operations. Her experience covers all Quality Systems; as well as, all areas of validation; including, process/product validation, facilities validation, CSV and 21 CFR Part 11, test method validation, equipment/automated processes and cleaning validation.Utilizing strategic thinking, risk based approaches, and Lean principles, she has demonstrated success in steering and managing complex projects within the pharmaceutical and medical device industries.
Upcoming Webinars

Data Integrity – In compliance with CSA, 21 CFR Part 11, Sa…

The five qualities every successful leader must develop

Better Business Writing-How to Write Right

Employee Handbooks: 2025 Critical Issues



Effectively Handle Toxic People for Better Productivity and…

Re-imagine Finance & Accounting Made Simple. Three Webinars…

ChatGPT and Project Management: Leveraging AI for Project M…

Data Privacy and Protection - Data protection laws and best…

How to Lead and Manage a Narcissistic Employee

Use of AI and GPT for Finance Professionals

Analytical Method Validation Under Good Laboratory Practic…

How to Write Contracts for Procurement Professionals

Excel What-If-Analysis Decision-Making Tools

Harassment, Bullying, Gossip, Confrontational and Disruptiv…

I-9 Audits: Strengthening Your Immigration Compliance Strat…

Maximizing Productivity with ChatGPT: AI Solutions for HR, …

Dealing With Difficult People: At Work & In Life


Excel - Reporting Simplified - Learn Pivot Tables from Scra…


Turning Workplace Conflict into Positive Connection

Project Management for Non-Project Managers - How to commun…

Retention Starts Here: Stop Losing Your Critical Talent and…

The Business Case for LGBTQIA+ Inclusion in the Workplace: …



Conquer Toxic People - Learn To Protect Yourself And Get Yo…

AI-Powered Change Leadership Operationalizing AI: Practical…

AI and Human Resources: The Great Opportunity!

Cyber Security Incident Response Team Training Program



Excel Power Skills: Master Functions, Formulas, and Macros …

Transforming Anger And Conflict Into Collaborative Problem …

The Courage to Speak: Overcoming Fear and Owning the Room

6-Hour Virtual Boot Camp on Microsoft Power BI


Finance & Accounting 101 Simplified

6-Hour Virtual Seminar on Learning the Highlights of Excel …